Glucose-insulin and potassium infusions in septic shock

Chest
Shahir S HamdulayHugh Montgomery

Abstract

Glucose-insulin and potassium (GIK) infusions are beneficial in treating ischemic myocardial depression. Myocardial depression is also an important feature in septic shock. We describe two cases of pressor-resistant hypodynamic septic shock that responded to high-dose GIK infusions. In each case, hemodynamic profiles improved sufficiently to allow withdrawal of vasopressor agents. Further assessment of GIK in patients with hypodynamic septic shock is necessary to confirm efficacy and prognostic significance.

References

Jul 1, 1985·Critical Care Medicine·W BronsveldL G Thijs
Jun 3, 1998·Intensive Care Medicine·R M Grocott-Mason, A M Shah
Feb 2, 1999·Circulation·C DepreH Taegtmeyer
Apr 18, 2000·Critical Care Clinics·A KumarJ E Parrillo
Apr 17, 2001·Heart·C J Broomhead, M P Colvin
Oct 3, 2002·Current Opinion in Critical Care·Sreenandh KrishnagopalanAnand Kumar
Sep 26, 2003·Current Opinion in Critical Care·Undurti N Das

❮ Previous
Next ❯

Citations

Jul 28, 2013·Inflammation·Yosef LevenbrownThomas H Shaffer
Oct 24, 2013·Critical Care Research and Practice·Estevão BassiLuciano Cesar Pontes Azevedo
Feb 14, 2016·Intensive Care Medicine·Davide Tommaso Andreis, Mervyn Singer
Apr 15, 2009·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Naa-Adjeley AblorhJoel S Holger
Jul 18, 2009·Biochimica Et Biophysica Acta·John C Chatham, Richard B Marchase
Apr 8, 2010·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Joel S HolgerJohn J Marini

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.